Medical Writing Health Economics and Market Access The Webscout
mew-150pxjpg

Volume 22, Issue 3 - Health Economics and Market Access

The Webscout

Abstract

Public health funding constitutes a big part of European social systems' expenditures. Governments and health insurance companies are thus interested in reducing spending. Applying pricing initiatives to innovative products confronts pharmaceutical companies with problems in the context of new product launches.

References

  1. Eichele K. The Webscout. Write Stuff 2011;1(20):52.

Search

Articles

Message from the President
Thirty-seventh EMWA Conference, 7–9 November 2013, Barcelona, Spain
Announcing the Geoff Hall Memorial Scholarships
Health economists and medical writers: Collaboration or collision?
Early benefit assessment of new drugs in Germany: Framework for submission of dossiers by pharmaceutical companies
NICE guidance on health technologies and the role of editors
European network for health technology assessment – EUnetHTA
Guest Editorial: Medical writing and health economics/market access: A health economist's view
Results of the 2012 EMWA salary survey
Successful document collaboration in a virtual team
Profile: An interview with Blanca Mayor Serrano on the state-of-the-art of health literacy in Spain
What can twitter do for me?
In the Bookstores
Journal Watch
The Webscout
Regulatory Writing Developments in paediatric regulation
English Grammar and Style
Medical Journalism
Medical Communications
Manuscript Writing
Out On Our Own
The Light Stuff

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: